What is the dose of epinephrine (adrenaline) for severe asthma exacerbations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing for Severe Asthma Exacerbations

For severe asthma exacerbations, subcutaneous epinephrine (concentration 1:1000) should be administered at 0.01 mg/kg, divided into 3 doses of approximately 0.3 mg given at 20-minute intervals. 1

Subcutaneous Administration

  • The standard adult dose is 0.3-0.5 mg subcutaneously every 20 minutes for 3 doses 1
  • For children, the dose is 0.01 mg/kg up to 0.3-0.5 mg every 20 minutes for 3 doses 1
  • Although epinephrine has nonselective adrenergic properties that may increase heart rate and myocardial irritability, it is generally well-tolerated even in patients over 35 years of age 1, 2

Intravenous Administration

  • For severe refractory asthma, IV epinephrine may be considered at an initial dose of 0.25-1 mcg/min as a continuous infusion 1
  • Caution is warranted with IV administration as one retrospective study indicated a 4% incidence of serious side effects 1
  • However, a small case series of younger adults with life-threatening asthma found IV epinephrine to be safe with no significant adverse events 3

Important Considerations

  • There is no evidence that subcutaneous epinephrine has advantages over inhaled β2-agonists for asthma exacerbations 1, 4
  • In patients with mild to moderate asthma, inhaled epinephrine is equally effective as injected epinephrine with fewer side effects 4
  • For severe airway obstruction (PEFR <25% of predicted), parenteral epinephrine may be superior to aerosol delivery 4
  • Nebulized epinephrine (1 mg) has been shown to be as effective as nebulized salbutamol (2.5 mg) in acute severe asthma 5

Treatment Algorithm

  1. First-line treatment: Use inhaled short-acting beta-agonists (albuterol 2.5-5 mg via nebulizer every 20 minutes for 3 doses) 6, 7
  2. Add ipratropium bromide (0.5 mg via nebulizer every 20 minutes for 3 doses) for severe exacerbations 6, 7
  3. Administer systemic corticosteroids early (prednisone 40-80 mg/day or equivalent) 6, 7
  4. For severe refractory asthma not responding to the above:
    • Consider subcutaneous epinephrine (0.01 mg/kg, ~0.3 mg per dose) every 20 minutes for 3 doses 1
    • Consider IV magnesium sulfate (2g over 20 minutes) 1, 7
    • For life-threatening cases, consider IV epinephrine (0.25-1 mcg/min) 1, 3

Cautions and Contraindications

  • Do not inject epinephrine into buttocks, digits, hands, or feet 8
  • Use with caution in patients with underlying heart disease, hyperthyroidism, Parkinson's disease, diabetes, and pheochromocytoma 8
  • Epinephrine may interact with cardiac glycosides, halogenated hydrocarbon anesthetics, tricyclic antidepressants, and MAO inhibitors 8
  • Monitor for adverse reactions including anxiety, tremor, palpitations, and arrhythmias 8

Monitoring

  • Continuously monitor oxygen saturation until a clear response to therapy has occurred 6, 7
  • Reassess patients 15-30 minutes after starting treatment 7
  • Response to treatment is a better predictor of hospitalization need than initial severity 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous epinephrine in life-threatening asthma.

Annals of emergency medicine, 2003

Research

Aerosol vs injected epinephrine in acute asthma.

Annals of emergency medicine, 1981

Research

Nebulised adrenaline in acute severe asthma: comparison with salbutamol.

European journal of respiratory diseases, 1987

Guideline

Asthma Exacerbation Management in Inpatients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.